secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001193125-23-164491
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma announces results of 2023 Annual Meeting; all director nominees elected
--------------------------------------------------------------------------------

- All 7 director nominees elected; Daniel Passeri received 11,665,042 for, 2,353,834 withheld.
- Ratification of RSM US LLP as auditor: 30,764,366 for, 105,334 against, 886,546 abstain.
- Say-on-pay approved with 11,079,655 for, 2,042,073 against, 897,148 abstain.
- Stockholders recommended annual say-on-pay votes; company will hold votes every year.
- Broker non-votes ranged from 17,737,370 across proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000119312523164491/0001193125-23-164491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000119312523164491/d459096d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-164491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer